NCT05209009View on ClinicalTrials.gov

A Clinical Trial of COVAC-2 in Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 24, 2022

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions
Severe Acute Respiratory Syndrome Coronavirus 2
Interventions
BIOLOGICAL

COVAC-2

Intramuscular vaccine against SARS-CoV-2

BIOLOGICAL

Saline Placebo

Intramuscular injection of saline placebo

Trial Locations (2)

Unknown

Uganda Virus Research Institute, Entebbe

Epicentre, Mbarara Research Centre, Mbarara

All Listed Sponsors
collaborator

Government of Canada

OTHER_GOV

collaborator

Government of Saskatchewan

OTHER_GOV

collaborator

Vaccine Formulation Institute (VFI)

UNKNOWN

collaborator

Seppic

INDUSTRY

lead

University of Saskatchewan

OTHER